HCA Healthcare (HCA)

NYSE Health Care Health Care Facilities S&P 500

$494.99

-12.49 (-2.46%)

Close of Nov 06, 2026 · end-of-day data

Source: HCA Healthcare's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$41.49B	$43.61B	$46.68B	$51.34B	$51.53B	$58.75B	$60.23B	$64.97B	$70.60B	$75.60B
Interest expense	$1.71B	$1.69B	$1.75B	$1.82B	$1.58B	$1.57B	$1.74B	$1.94B	$2.06B	$2.25B
Pre-tax income	$4.81B	$4.38B	$5.33B	$5.24B	$5.43B	$9.83B	$8.58B	$7.71B	$8.52B	$9.83B
Income tax	$1.38B	$1.64B	$946.00M	$1.10B	$1.04B	$2.11B	$1.75B	$1.61B	$1.87B	$2.05B
Net income	$2.89B	$2.22B	$3.79B	$3.50B	$3.75B	$6.96B	$5.64B	$5.24B	$5.76B	$6.78B
EPS (basic)	$7.53	$6.12	$10.90	$10.27	$11.10	$21.52	$19.43	$19.25	$22.27	$28.70
EPS (diluted)	$7.30	$5.95	$10.66	$10.07	$10.93	$21.16	$19.15	$18.97	$22.00	$28.33
Diluted shares	395.85M	372.22M	355.30M	348.23M	343.61M	328.75M	294.67M	276.41M	261.81M	239.50M
Net margin	7.0%	5.1%	8.1%	6.8%	7.3%	11.8%	9.4%	8.1%	8.2%	9.0%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$646.00M	$732.00M	$502.00M	$621.00M	$1.79B	$1.45B	$908.00M	$935.00M	$1.93B	$1.04B
Short-term investments	—	—	—	—	$116.00M	$103.00M	—	—	—	—
Receivables	$5.83B	$6.50B	$6.79B	$7.38B	$7.05B	$8.10B	$8.89B	$9.96B	$10.75B	$10.87B
Inventory	$1.50B	$1.57B	$1.73B	$1.85B	$2.02B	$1.99B	$2.07B	$2.02B	$1.74B	$1.65B
Total current assets	$9.09B	$9.98B	$10.21B	$11.20B	$12.33B	$13.54B	$13.64B	$14.93B	$16.41B	$15.78B
Total assets	$33.76B	$36.59B	$39.21B	$45.06B	$47.49B	$50.74B	$52.44B	$56.21B	$59.51B	$60.72B
Total current liabilities	$5.83B	$6.16B	$7.57B	$7.76B	$8.70B	$9.58B	$9.90B	$12.65B	$15.18B	$16.35B
Short-term debt	$216.00M	$200.00M	$788.00M	$145.00M	$209.00M	$237.00M	$370.00M	$2.42B	$4.70B	$4.89B
Long-term debt	$31.16B	$32.86B	$32.03B	$33.58B	$30.80B	$34.34B	$37.71B	$37.17B	$38.33B	$41.60B
Total debt	$31.38B	$33.06B	$32.82B	$33.72B	$31.00B	$34.58B	$38.08B	$39.59B	$43.03B	$46.49B
Total liabilities	$39.39B	$41.59B	$42.12B	$45.62B	$46.92B	$51.67B	$55.20B	$57.98B	$62.01B	$66.75B
Shareholders' equity	-$7.30B	-$6.81B	-$4.95B	-$2.81B	$572.00M	-$933.00M	-$2.77B	-$1.77B	-$2.50B	-$6.03B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$5.65B	$5.43B	$6.76B	$7.60B	$9.23B	$8.96B	$8.52B	$9.43B	$10.51B	$12.64B
Capital expenditures	$2.76B	$3.02B	$3.57B	$4.16B	$2.83B	$3.58B	$4.39B	$4.74B	$4.88B	$4.94B
Free cash flow	$2.89B	$2.41B	$3.19B	$3.44B	$6.40B	$5.38B	$4.13B	$4.69B	$5.64B	$7.69B
Investing cash flow	-$3.24B	-$4.28B	-$3.90B	-$5.72B	-$3.39B	-$2.64B	-$3.39B	-$5.32B	-$4.93B	-$4.99B
Financing cash flow	-$2.51B	-$1.06B	-$3.08B	-$1.77B	-$4.68B	-$6.66B	-$5.66B	-$4.09B	-$4.58B	-$8.55B
Dividends paid	—	$0	$487.00M	$550.00M	$153.00M	$624.00M	$653.00M	$661.00M	$690.00M	$679.00M
Share buybacks	$2.75B	$2.05B	$1.53B	$1.03B	$441.00M	$8.21B	$7.00B	$3.81B	$6.04B	$10.07B
Stock-based compensation	$251.00M	$270.00M	$268.00M	$347.00M	$362.00M	$440.00M	$341.00M	$262.00M	$360.00M	$401.00M
Depreciation & amortization	$1.97B	$2.13B	$2.28B	$2.60B	$2.72B	$2.85B	$2.97B	$3.08B	$3.31B	$3.52B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$17.30B	$17.34B	$17.49B	$17.49B	$18.29B	$18.32B	$18.61B	$19.16B	$19.51B	$19.11B	$20.23B	$19.85B
Interest expense	$491.00M	$512.00M	$506.00M	$515.00M	$528.00M	$547.00M	$568.00M	$561.00M	$572.00M	$584.00M	$599.00M	$607.00M
Pre-tax income	$2.35B	$2.25B	$2.24B	$1.91B	$2.13B	$2.33B	$2.42B	$2.42B	$2.67B	$2.29B	$2.49B	$2.37B
Income tax	$484.00M	$445.00M	$550.00M	$424.00M	$447.00M	$502.00M	$524.00M	$515.00M	$509.00M	$430.00M	$564.00M	$521.00M
Net income	$1.61B	$1.59B	$1.46B	$1.27B	$1.44B	$1.61B	$1.65B	$1.64B	$1.88B	$1.62B	$1.70B	$1.58B
EPS (basic)	$5.99	$6.01	$5.60	$4.94	$5.70	$6.52	$6.91	$7.05	$8.23	$7.25	$7.70	$7.36
EPS (diluted)	$5.90	$5.93	$5.53	$4.88	$5.63	$6.45	$6.83	$6.96	$8.10	$7.15	$7.62	$7.27
Diluted shares	-1.76M	268.02M	264.07M	259.92M	-2.18M	249.44M	241.91M	236.18M	-2.96M	226.65M	222.83M	217.21M
Net margin	9.3%	9.2%	8.4%	7.3%	7.9%	8.8%	8.9%	8.6%	9.6%	8.5%	8.4%	8.0%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$935.00M	$1.28B	$831.00M	$2.89B	$1.93B	$1.06B	$939.00M	$997.00M	$1.04B	$940.00M	$1.01B	$908.00M
Receivables	$9.96B	$10.04B	$10.24B	$9.91B	$10.75B	$11.09B	$10.46B	$10.43B	$10.87B	$11.32B	$12.28B	$11.51B
Inventory	$2.02B	$1.90B	$1.80B	$1.78B	$1.74B	$1.79B	$1.79B	$1.73B	$1.65B	$1.68B	$1.66B	$1.67B
Total current assets	$14.93B	$15.28B	$15.17B	$16.66B	$16.41B	$16.26B	$15.56B	$15.29B	$15.78B	$16.05B	$17.19B	$16.22B
Total assets	$56.21B	$56.96B	$57.38B	$59.46B	$59.51B	$59.80B	$59.54B	$59.75B	$60.72B	$61.45B	$63.25B	$63.45B
Total current liabilities	$12.65B	$13.14B	$14.30B	$14.90B	$15.18B	$13.63B	$15.94B	$17.90B	$16.35B	$19.26B	$17.31B	$19.78B
Short-term debt	$2.42B	$3.03B	$4.57B	$4.68B	$4.70B	$3.52B	$5.10B	$6.11B	$4.89B	$8.53B	$6.26B	$8.09B
Long-term debt	$37.17B	$37.16B	$36.31B	$38.28B	$38.33B	$41.06B	$39.38B	$38.40B	$41.60B	$39.49B	$43.45B	$42.40B
Total debt	$39.59B	$40.19B	$40.88B	$42.97B	$43.03B	$44.58B	$44.48B	$44.51B	$46.49B	$48.02B	$49.72B	$50.49B
Total liabilities	$57.98B	$58.58B	$58.98B	$61.64B	$62.01B	$63.32B	$63.93B	$65.08B	$66.75B	$67.75B	$69.89B	$71.53B
Shareholders' equity	-$1.77B	-$1.61B	-$1.60B	-$2.18B	-$2.50B	-$3.52B	-$4.39B	-$5.33B	-$6.03B	-$6.30B	-$6.64B	-$8.08B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$2.67B	$2.47B	$1.97B	$3.52B	$2.56B	$1.65B	$4.21B	$4.42B	$2.36B	$2.01B	$2.33B	$4.46B
Capital expenditures	$1.16B	$1.12B	$1.28B	$1.19B	$1.28B	$991.00M	$1.18B	$1.29B	$1.49B	$1.12B	$1.23B	$1.36B
Free cash flow	$1.51B	$1.35B	$690.00M	$2.32B	$1.27B	$660.00M	$3.03B	$3.13B	$870.00M	$895.00M	$1.10B	$3.10B
Investing cash flow	-$1.60B	-$903.00M	-$1.33B	-$1.35B	-$1.35B	-$1.03B	-$1.25B	-$1.39B	-$1.32B	-$1.28B	-$1.56B	-$1.92B
Financing cash flow	-$1.04B	-$1.22B	-$1.09B	-$110.00M	-$2.16B	-$1.50B	-$3.09B	-$2.97B	-$999.00M	-$830.00M	-$704.00M	-$2.65B
Dividends paid	$160.00M	$185.00M	$171.00M	$169.00M	$165.00M	$180.00M	$171.00M	$166.00M	$162.00M	$183.00M	$171.00M	$165.00M
Share buybacks	$910.00M	$1.18B	$1.37B	$1.79B	$1.70B	$2.51B	$2.50B	$2.50B	$2.56B	$1.57B	$2.06B	$2.97B
Stock-based compensation	$57.00M	$87.00M	$112.00M	$76.00M	$85.00M	$98.00M	$99.00M	$104.00M	$100.00M	$86.00M	$85.00M	$133.00M
Depreciation & amortization	$789.00M	$795.00M	$819.00M	$842.00M	$856.00M	$860.00M	$863.00M	$889.00M	$911.00M	$930.00M	$944.00M	$954.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.